International Journal of Obstetric Anesthesia
Volume 17, Issue 2 , Pages 130-136 , April 2008

Remifentanil for cesarean section under general anesthesia: effects on maternal stress hormone secretion and neonatal well-being: a randomized trial

References 

  1. Cooper GM. Maternal death from anesthesia. An extract from Why mothers die 2000-2002, the Confidential Enquiries into Maternal Deaths in the United Kingdom: Chapter 9: Anesthesia. Br J Anaesth. 2005;94:417–423
  2. Reynolds F, Seed PT. Anaesthesia for Caesarean section and neonatal acid-base status: a meta-analysis. Anaesthesia. 2005;60:636–653
  3. Kehlet H, Dahl JB. Anesthesia, surgery, and challenges in postoperative recovery. Lancet. 2003;362:1921–1928
  4. Desborough JP. The stress response to trauma and surgery. Br J Anaesth. 2000;85:109–117
  5. Vogl SE, Worda C, Egarter C, et al. Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG. 2006;113:441–445
  6. Morishima HO, Pederson H, Finster M, et al. Influence of maternal physiologic stress on the fetus. Am J Obstet Gynecol. 1978;131:286–290
  7. Ngan Kee W, Khaw KS, Ma KC, Wong AS, et al. Maternal and neonatal effects of remifentanil at induction of general anesthesia for Cesarean delivery: a randomized, double–blind, controlled trial. Anesthesiology. 2006;104:14–2010
  8. Wadsworth R, Greer R, MacDonald JMS, Vohra A. The use of remifentanil during general anesthesia for cesarean delivery in two patients with severe heart dysfunction. Int J Obstet Anesth. 2002;2:38–43
  9. Orme RML, Grange CS, Ainsworth QP, et al. General anesthesia using Remifentanil for cesarean section in parturients with critical aortic stenosis: a series of four cases. Int J Obstet Anesth. 2004;13:183–187
  10. Imarengiaye C, Littleford J, Davies S, et al. Goal oriented general anesthesia for cesarean section in a parturient with a large intracranial epidermoid cyst. Can J Anesth. 2001;48:884–889
  11. Richa F, Yazigi A, Nasser E, et al. General anesthesia with remifentanil for cesarean section in a patient with HELLP syndrome. Acta Anaesthesiol Scand. 2005;49:418–420
  12. Carvalho B, Mirikitani EJ, Lyell D, Evans DA, Druzin M, Riley ET. Neonatal chest wall rigidity following the use of remifentanil for cesarean delivery in a patient with autoimmune hepatitis and thrombocytopenia. Int J Obstet Anesth. 2004;13:53–56
  13. Van de Velde M, Teunkens A, Kuypers M, et al. General anesthesia with target controlled infusion of propofol for planned cesarean section: maternal and neonatal effects of a remifentanil-based technique. Int J Obstet Anesth. 2004;13:153–158
  14. Fukuda K. Intravenous opioid anesthetics. In:  Miller RD editors. Miller’s Anesthesia. 6th ed.. Philadelphia: Elsevier-Churchill-Livingstone; 2005;p. 379–437
  15. American Heart Association, American Academy of Pediatrics. 2005 American Heart Association (AHA) Guidelines for Cardiopulmonary Resuscitation (CPR) and Emergency Cardiovascular Care (ECC) of Pediatric and Neonatal Patients: Neonatal Resuscitation Guidelines. Pediatrics 2006; 117; e1029-e1038.
  16. Bossù E, Montinaro A, Lecce R et al. LC-MS Determination of remifentanil in maternal and neonatal plasma. J Pharm Biomed Anal 2006 Sep 26; 42: 367-71. Epub 2006 June 30.
  17. Pocock SJ. Clinical Trials: A Practical Approach. Wiley; 1996;
  18. Kan RE, Hughes SC, Rosen MA, Kessin C, Preston PG, Lobo EP. Intravenous remifentanil. Placental transfer, maternal and neonatal effects. Anesthesiology. 1998;88:1467–1474
  19. Littleford J. Effects on the fetus and newborn of maternal analgesia and anesthesia: a review. Can J Anesth. 2004;51:586–589
  20. Furuya K, Shimizu R, Hirabayashi Y, Ishii R, Fukuda H. Stress hormone responses to major intra-abdominal surgery during and immediately after sevoflurane-nitrous oxide anesthesia in elderly patients. Can J Anaesth. 1993;40:435–439
  21. Wilmore DW. From Cuthbertson to fast-track surgery: 70 years of progress in reducing stress in surgical patients. Ann Surg. 2002;236:643–648
  22. Traynor C, Hall GM. Endocrine and metabolic changes during surgery. Anaesthetic implications. Br J Anaesth. 1981;53:153–160
  23. Kehlet H. Modification of responses to surgery by neural blockade: clinical implications. In:  Cousins MJ,  Bridenbaugh PO editor. Neural blockade in clinical anesthesia and management of pain. Philadelphia: Lippincott; 1998;p. 129–175
  24. Scarborough DE. Cytokine modulation of pituitary hormone secretion. Ann NY Acad Sci. 1990;594:169–187
  25. Rittmaster RS, Cutler GB, Sobel DO, et al. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab. 1985;60:891–895
  26. Schricker T, Carli F, Schreiber M, et al. Propofol/Sufentanil anesthesia suppresses the metabolic and endocrine response during, not after, lower abdominal surgery. Anesth Analg. 2000;90:450–455
  27. Giesecke K, Hamberger B, Jarnberg PO, et al. High- and low-dose fentanyl anesthesia: hormonal and metabolic responses during cholecystectomy. Br J Anaesth. 1988;61:575–582
  28. Raeder JC, Hole A. Alfentanil anesthesia in gall-bladder surgery. Acta Anaesthesiol Scand. 1986;30:35–40
  29. Gin T, Ngan-kee WD, Siu YK, et al. Alfentanil given immediately before the induction of anesthesia for elective cesarean delivery. Anesth Analg. 2000;90:1167–1172
  30. Myre K, Raeder J, Rostrup M, et al. Catecholamine release during laparoscopic funduplication with high and low dose of remifentanil. Acta Anaesthesiol Scand. 2003;47:267–273
  31. Halter JB, Pflug AE, Porte D. Mechanism of plasma catecholamine increases during surgical stress in man. J Clin Endocrinol Metab. 1977;45:936–944
  32. Esler M, Jennings G, Lambert G, et al. Overflow of catecholamine neurotransmitters to the circulation. Source, Fate, Functions. Physiol Rev. 1990;70:963–985

PII: S0959-289X(08)00003-4

doi: 10.1016/j.ijoa.2008.01.002

International Journal of Obstetric Anesthesia
Volume 17, Issue 2 , Pages 130-136 , April 2008

Article Tools

* Image Usage & Resolution